Zepp Health (ZEPP) Stock Overview
Operates as a smart wearable and health technology company worldwide. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
ZEPP Community Fair Values
Create NarrativeSee what 9 others think this stock is worth. Follow their fair value or set your own to get alerts.
Zepp Health Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.06 |
| 52 Week High | US$24.44 |
| 52 Week Low | US$2.06 |
| Beta | 1.12 |
| 1 Month Change | 707.38% |
| 3 Month Change | 850.99% |
| 1 Year Change | 1,057.40% |
| 3 Year Change | 251.75% |
| 5 Year Change | -55.31% |
| Change since IPO | -46.53% |
Recent News & Updates
Recent updates
Zepp Health Corporation (NYSE:ZEPP) Soars 336% But It's A Story Of Risk Vs Reward
Aug 04
Investors Give Zepp Health Corporation (NYSE:ZEPP) Shares A 29% Hiding
Apr 18
AI-powered T-Rex 3 And Amazfit Releases Will Redefine Future Possibilities
Transition to a high-margin business model and AI-powered product launches likely to enhance profitability and drive significant revenue growth.Zepp Health Corporation (NYSE:ZEPP) Stock Catapults 26% Though Its Price And Business Still Lag The Industry
Aug 20Calculating The Intrinsic Value Of Zepp Health Corporation (NYSE:ZEPP)
Aug 03Zepp Health Corporation (NYSE:ZEPP) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough
Apr 17Zepp Health Corporation's (NYSE:ZEPP) Price Is Right But Growth Is Lacking After Shares Rocket 30%
Dec 23Zepp Leaves Investors Guessing With Return To Profits, Tumbling Own-Brand Sales
Nov 24Can Zepp Health Find Its Way Back Up?
Jul 31Zepp Health Non-GAAP EPADS of -$0.23, revenue of $165.5M
Aug 25What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Aug 12Zepp: Speculative, But With Potentially Great Rewards
Jun 08What Does Zepp Health Corporation's (NYSE:ZEPP) Share Price Indicate?
Mar 16Is Zepp Health Corporation (NYSE:ZEPP) Worth US$3.8 Based On Its Intrinsic Value?
Feb 23Zepp Health Stuck In Rut As Global Chip Shortage, Covid Weigh
Jan 06Shareholder Returns
| ZEPP | US Electronic | US Market | |
|---|---|---|---|
| 7D | 91.4% | -1.7% | -1.2% |
| 1Y | 1,057.4% | 40.2% | 21.3% |
Return vs Industry: ZEPP exceeded the US Electronic industry which returned 43.8% over the past year.
Return vs Market: ZEPP exceeded the US Market which returned 22.8% over the past year.
Price Volatility
| ZEPP volatility | |
|---|---|
| ZEPP Average Weekly Movement | 32.2% |
| Electronic Industry Average Movement | 7.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 17.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: ZEPP's share price has been volatile over the past 3 months compared to the US market.
Volatility Over Time: ZEPP's weekly volatility has increased from 20% to 32% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2013 | 765 | Wayne Huang | www.huami.com |
Zepp Health Corporation operates as a smart wearable and health technology company worldwide. The company empowers users to live lives by optimizing health, fitness, and wellness journeys through its consumer brands, Amazfit, Zepp Clarity, and Zepp Aura. The company through its proprietary Zepp Digital Management Platform, which includes the Zepp OS, AI chips, biometric sensors, and data algorithms, delivers cloud-based 24/7 actionable insights and guidance to help users attain wellness goals.
Zepp Health Corporation Fundamentals Summary
| ZEPP fundamental statistics | |
|---|---|
| Market cap | US$250.30m |
| Earnings (TTM) | -US$77.61m |
| Revenue (TTM) | US$199.95m |
Is ZEPP overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| ZEPP income statement (TTM) | |
|---|---|
| Revenue | US$199.95m |
| Cost of Revenue | US$124.92m |
| Gross Profit | US$75.03m |
| Other Expenses | US$152.63m |
| Earnings | -US$77.61m |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
n/a
| Earnings per share (EPS) | -5.40 |
| Gross Margin | 37.52% |
| Net Profit Margin | -38.81% |
| Debt/Equity Ratio | 46.8% |
How did ZEPP perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/08/05 10:12 |
| End of Day Share Price | 2025/08/05 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Zepp Health Corporation is covered by 4 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ang-Chi Lin | Citigroup Inc |
| null null | Credit Suisse |
| Siddharth Rajeev | Fundamental Research Corp. |